Searched for
GLENMARK MARCH QUARTER
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Glenmark Pharma to sell 7.84% stake in Glenmark Life via OFSThe stake sale will be done through the stock exchanges via an offer for sale (OFS). The decision was made at a meeting held today, and the...
- Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoYGlenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss ...
- Glenmark reports Rs 403 crore loss in Q4FY23For the fourth quarter of FY23, Glenmark’s consolidated revenue was at Rs. 3374 crore as against Rs.3019 crore in the same quarter of previ...
- Glenmark Pharma Q4 Results: Profit declines 12.3% on higher input costs and lower demandGlenmark Pharmaceuticals' Q4 consolidated profit before exceptional items and tax was INR3.09bn ($37.78m) for the quarter ended 31 March, d...
- Glenmark Q4 Results: Net dips 26% to Rs 173 crConsolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the ye...
- Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 crIts consolidated revenue from operations stood at Rs 2,859.9 crore for the quarter under consideration. It was Rs 2,767.5 crore for the sam...
- Brokerages’ views mixed on Glenmark PharmaShares of Glenmark declined 3.7 per cent to close at Rs 450 on Tuesday.
- Neutral on Glenmark Pharma, target price Rs 430: Motilal OswalThe brokerage values Glenmark Pharma on a 13 times 12 month forward earnings basis to arrive at a price target of Rs 430.
- Glenmark Pharma Q4 results: Net profit jumps 36% to Rs 220 croreThe Mumbai-based drug firm had reported a net profit of Rs 161.66 crore for the corresponding period of 2018-19.
- Glenmark Pharma registers biggest intraday fall in 7 years post Q4 resultsLower than expected financial performance resulted in plunging of the shares.
- Glenmark Q4 net up 23.5% to Rs 184 croreConsolidated revenue from operations of the company also rose to Rs 9,185.68 crore for the financial year ended March 2017. It was Rs 7,649...
- Glenmark Pharmaceuticals reports Q4 net profit at Rs 10.61 croreGlenmark Pharmaceuticals reported a consolidated net profit of Rs 10.61 crore for the fourth quarter ended March 31, 2015.
- Glenmark Pharma Q4 net profit at Rs 43 croreConsolidated net sales of the company rose to Rs 1,681.74 crore for the fourth quarter, as against Rs 1,335.48 crore in the same period of ...
- Glenmark Q4 Net up 11 pc at Rs 167 croreGlenmark Pharmaceuticals today posted 10.93 per cent rise in consolidated net profit at Rs 166.79 crore for the fourth quarter ended March ...
- Glenmark Q4 net up 33 per cent at Rs 150 croreGlenmark Pharmaceuticals today said its consolidated net profit rose by 32.54 per cent to Rs 150.35 crore for the fourth quarter ended Marc...
- Glenmark gets most approvals to sell generic drugs in USRanbaxy, now owned by Japan’s Daiichi Sankyo, may get nod to sell generic version of world’s best selling drug Lipitor worth over $12 billi...
- Medicis deal, generic biz to boost financialsRecent developments could well be a pointer to better days ahead for Glenmark Pharma which has had a relatively poor performance in the pas...
- Glenmark down 28% on bad resultsShares of Glenmark Pharmaceuticals plunged 28% as investors started to discount the bad results posted by the company for the third quarter.
- Glenmark Q1 net triples to Rs 57 crGlenmark Pharmaceuticals’ net profit more than tripled to Rs 57.2 crore during the first quarter ended June 2007 on the back of overseas ac...
Load More
